TruthArchive.ai - Related Video Feed

The speaker emphasizes the lengthy process of developing a safe and effective vaccine, usually taking 10 to 25 years. They mention a potential safety issue with coronavirus vaccines, where immunization may lead to immune enhancement when exposed to the virus. This phenomenon has been observed in laboratory animals. Despite this concern, the speaker expresses enthusiasm for the approval of the second vaccine, stating that if enough Americans get vaccinated, virus transmission could be halted. They also mention the availability of new boosters, recommending anyone who is safe to get them for added protection.

Today, the speaker discusses the transmission and viral load of vaccinated individuals compared to unvaccinated individuals. They mention the example of Israel, where a professor from Tel Aviv hospital stated that 75% of hospitalized patients were vaccinated. The speaker argues against the narrative that vaccinated individuals are solely responsible for immunity. They emphasize that the disease has a low mortality rate and question the need for continued booster shots. The other speaker counters by stating that vaccines protect against severe forms of the virus, particularly for those under 60 years old. The conversation ends with a disagreement about the percentage of vaccinated individuals in hospitals.

The speakers emphasize the importance of vaccination in reducing transmission and returning to normalcy. They mention that vaccinated individuals do not carry the virus or get sick. Getting vaccinated and receiving booster shots can save lives, protect loved ones, and prevent the spread of infection. The vaccines effectively stop the virus with each vaccinated person, preventing it from using them as a host to infect others. However, the speakers acknowledge that the initial data on vaccine transmission was limited, and they did not have a clear answer on whether the vaccines would stop infection. They stress the need for people to take the vaccines to break the chain of transmission.

Speaker 0 warns that the g n one mutations are very alarming because the mutations are no longer restricted to spike protein, which indicates enhanced activity of CTLs to diminish viral infectiousness, and that CTL activity is responsible for the decline of T cells that in fact boost the non neutralizing antibodies that prevent virulence. He says that this is why he has been predicting that evolution would inevitably lead to the emergence of a highly virulent variant that would cause waves of hospitalization and severe disease in highly vaccinated countries. Speaker 1 acknowledges and asks for quantification, wondering if this will lead to more deaths and how many, seeking precise figures. Speaker 0 refrains from giving specific numbers, stating that it is not due to fear of figures but because it is unprecedented. He says what we will see is something completely, completely unprecedented in terms of the magnitude of the wave of morbidity and, unfortunately, mortality that we will see. Speaker 1 presses for a multiplier (10x, 5x, 3x, 20x). Speaker 0 responds that in highly vaccinated populations, depending on age, vaccine coverage, and vaccination speed, we might be dealing with serious decimation of the population, with some populations potentially seeing up to thirty to forty percent.

Speaker 0: The vaccine works against it or or it's unsure at this point? Speaker 1: Well, we don't know. For the c one two, we don't know. Right now, vaccines do work, but, obviously, they work against hospitalizations and deaths Yeah. Really well. Before just casual breakthrough mild infections with Delta has taught us that there's a lot more breakthroughs than we know. And after six months, it does tend to wane a little bit. And hence, Israel is going for third booster shot starting October 1. Unless you're triple vaxxed, you're not considered fully vaxxed. Speaker 0: Wow. Speaker 1: And that approach, as much as it sucks, is the reality that with the face of these new variants. This is why the sooner we end it, the sooner we can stop dealing with these upgrade software upgrade patches that we have to do with our vaccines. But

Investing in vaccines is crucial for stopping COVID transmission and returning to normalcy. Vaccinated individuals are protected from severe illness and can resume activities without masks. However, reports show a decline in immunity over time, necessitating booster shots. The goal is to increase immunity levels to minimize infections. The effectiveness of vaccines against variants is emphasized, highlighting the importance of getting vaccinated.

The speakers discuss the effectiveness of COVID-19 vaccines and the importance of getting vaccinated. They emphasize that vaccinated individuals are less likely to get infected, transmit the virus, or experience severe illness. They mention that vaccines slightly reduce transmission but do not completely prevent it. The speakers also mention the possibility of waning immunity over time and suggest that booster shots may be necessary. They encourage everyone to get vaccinated and highlight the goal of achieving high immunity levels to return to normalcy. The plan is for every adult to receive a booster shot.

The speaker argues that people don’t feel like going to the stadium due to infection risk and that you don’t have a choice; it’s not the government telling them to ignore the disease. People are deeply affected by seeing these deaths and by knowing they could be part of the transmission chain, with old people, their parents, and grandparents potentially affected. There will be the ability, particularly in rich countries, to open up if things are done well over the next few months. But for the world at large, normalcy only returns when we've largely vaccinated the entire global population.

The massive vaccination of the population likely led to the current situation. The virus has become less virulent, but the vaccine does not provide complete immunity. It protects individuals but does not directly protect the community. However, it indirectly helps protect the community. There is controversy surrounding whether the vaccine prevents transmission, but it is known to prevent severe symptoms in individuals. The vaccine allows individuals to develop a functional immune memory that helps avoid severe forms of the disease.

The speakers discuss the expected mutation of the virus and the impact of vaccination. They acknowledge that as people become immunized, the virus will try to find ways to evade the vaccine. The more people are vaccinated, the more pressure is put on the virus to mutate. Some virologists warn that vaccinating the entire world with narrow immunity could lead to the emergence of superbugs. They urge for the use of the right vaccine in the right place and caution against mass vaccination during a pandemic. They argue that current interventions and mass vaccination may be causing more harm than good, driving the emergence of more infectious and potentially lethal variants.

The vaccine is effective against infection and transmission, but immunity decreases after 6 months. A booster or third dose is needed to restore immunity. Translation: The vaccine works well against getting sick and spreading the virus, but protection weakens after 6 months. To boost immunity, a third dose is necessary.

The speaker questions why there hasn't been research done to show that natural immunity protects against recurrent infection. They mention that studies have shown that individuals with natural immunity have antibodies, T cells, and B cells that are considered adequate for protection. The speaker also mentions that the CDC has access to patient data. However, the other speaker responds by stating that their current stance is that everyone who has been previously infected should still be vaccinated, without directly addressing the question.

The transcript argues that more dangerous SARS-CoV-2 variants could arise by creating biological niches for variants and through VADES, with the speaker stating that “viral immune escape threatens to play a catastrophic role in the COVID mass vaccinated world.” It describes the virus as originally relatively harmless with a very low death percentage for healthy young people, potentially evolving into a seasonal virus with an even lower death percentage. However, it is claimed that mass vaccination could disturb this natural progression and cause resistant, and potentially more dangerous and more contagious variants by creating biological niches for those variants. The speaker asserts a correlation between the rise of variants and the increase of vaccinations, stating that “the rise of variants correlates with the increase of vaccinations.” In this context, viral immune escape is mentioned, and antibody-dependent enhancement (ADE) is noted as a phenomenon that can worsen disease; the speaker notes that ADE is known to be an issue with coronaviruses and was an issue in animal trials for SARS vaccines, and is associated with SARS and severe COVID itself. The claim is made that as more vaccines and different vaccine types are administered, and as more COVID variants succeed, the ADE risk increases. According to the speaker, given these considerations, the worldwide mass vaccination agenda is described as a “haste and rush agenda,” very dangerous and destined to become a failure. The speaker questions whether “the mass vaccination induced immune escape COVID killing waves and vades” are coming for the COVID vaccinated. To illustrate the situation, the transcript cites a series of record-high stretcher occupancy values in Quebec, across several dates in 2024: 07/08/2024 – 2,319; 07/08/2024 – 2,370; 08/06/2024 – 2,384; 08/27/2024 – 2,395; 08/24/24 – 2,412; 09/03/2024 – 2,444. The source cited is Sourcetumia.org, with a request to “please like and follow.”

The speaker discusses the evolution of the COVID-19 pandemic from an acute phase to a chronic phase. They explain that the suboptimal immune response caused by vaccination is leading to immune escape and immune pathology. The virus is continuing to evolve and will eventually overcome the suboptimal forces, leaving no immune resistance in the vaccinated population. The unvaccinated population, on the other hand, has been able to train their immune system and still has immune defense. The speaker emphasizes the importance of antiviral treatments like ivermectin in preventing reinfections and recommends taking them prophylactically. They predict a hyperacute phase of the disease and believe that the current public health authorities will be held accountable for their actions.

The speaker discusses the challenge of achieving population immunity against the virus. They explain that continually vaccinating the entire population every few months is not feasible, so the virus needs to circulate and update people's immunity. However, it is uncertain if Germany can afford to allow the virus to circulate due to the vaccine gap. This is the main obstacle, and it is difficult to predict the outcome. The speaker mentions that some studies show the effectiveness of second and third doses in preventing severe illness, but it is challenging to estimate the number of vaccinated individuals and the extent of the vaccine gap. They conclude that while the virus needs to circulate eventually, it may not be the right time for Germany yet, unlike in other countries.

The speakers discuss the need for vaccines to combat the spread of the virus. They mention that traditional vaccines require booster shots to increase protection over time, but it is uncertain if the same applies to the RNA vaccines. They mention the possibility of a fourth dose and the uncertainty surrounding the duration of immunity. They acknowledge that the situation with the virus is unique and express a tolerance for doubts and questions.

On the topic of the effectiveness of vaccines in controlling the epidemic, the speaker disagrees with the authorities. They state that vaccines do not control the spread of the virus, as countries with higher vaccination rates also have higher case numbers. They suggest that there may be a scientific phenomenon where the number of infection cases increases within 15 days to three weeks after vaccination. This phenomenon, related to facilitating antibodies, has not been sufficiently analyzed or studied in epidemiology. The speaker is Professor Raoul.

The massive vaccination of the population has likely led to the current situation. The virus has become less virulent, but the vaccine does not provide complete immunity. It protects individuals but does not directly protect the community. However, it indirectly helps protect the community. There is controversy surrounding whether the vaccine prevents transmission, but it is known to prevent individual problems. It has allowed individuals to develop a functional immune memory that helps prevent severe forms of the disease.

The discussion centers on a concerning viral evolution where mutations are no longer restricted to the spike protein. Speaker 0 argues that this indicates enhanced activity of cytotoxic T lymphocytes (CTLs) to diminish viral infectiousness, and that CTL activity is responsible for the decline of T cells that in turn boost non-neutralizing antibodies that prevent virulence. Based on this, Speaker 0 has been predicting that the evolution would inevitably lead to the emergence of a highly virulent variant that would cause waves of hospitalization and severe disease, even in highly vaccinated countries. The claim emphasizes that such waves would occur specifically in countries with high vaccination coverage. Speaker 1 seeks clarification, asking if what is coming is essentially “act two” with more people infected and potentially more deaths, and requests a quantifiable estimate. Speaker 0 acknowledges the request but resists providing exact figures, stating it is not due to fear of numbers but because it would be inappropriate to preface the prediction with precise statistics. He describes the anticipated outcome as “something completely, completely unprecedented in terms of the magnitude of the wave of morbidity and and, unfortunately, mortality that we will see.” When pressed again for quantification, Speaker 0 references observed data from highly vaccinated populations, noting that outcomes depend on age, vaccine coverage, and the speed of vaccination. He cautions that he would not be surprised if the situation leads to a “serious decimation of the population” in certain groups, with estimates suggesting potential impacts “in some populations, maybe up to thirty, forty percent.” In summary, the speakers describe a scenario where non-spike mutations suggest enhanced CTL-driven changes in infectiousness and immune response, forecast the emergence of a highly virulent variant capable of causing waves of severe disease even in highly vaccinated countries, and project the possibility of substantial morbidity and mortality in the coming waves, with some populations facing as much as 30–40 percent impact.

The speaker agrees that the current vaccination rate is unlikely to slow down the epidemic, which is primarily due to the strict lockdown measures. However, it will help reduce the pressure on hospitals once the lockdown is lifted. If the epidemic were to resurge, it would not affect the elderly and high-risk individuals, so there would be no need for another lockdown. Additionally, the number of vaccinated individuals will continue to increase. The positive results from Israel suggest that vaccination significantly reduces virus transmission, which is a promising outcome even if the entire population is not vaccinated.

Speaker 0 and Speaker 1 repeatedly describe the virus as actively targeting unvaccinated people. They state, “If you are unvaccinated and the virus comes into your community, the virus will hunt you out. The virus hunts down the unvaccinated,” and insist, “The virus will find the unvaccinated. That’s what they all say. And it’s a virus that will find you if you’re not vaccinated.” They emphasize that “the virus is literally finding unvaccinated people” and that “the virus will find you” if you remain unvaccinated, especially when you are in circulation. The speakers highlight the Delta variant as particularly dangerous, saying, “The Delta variant of COVID nineteen has the potential to spread through an unvaccinated community like wildfire,” and describing Delta as “so aggressive,” asserting that “If you are unvaccinated, it’s gonna find you,” and reiterating, “Delta is finding the unvaccinated. The Delta variant will find you. If you’re not vaccinated, it will find you.” They argue the risk is not confined to crowded urban areas but “tends to find places that are under vaccinated.” The virus, they say, “does not just move to city centers. It finds the unvaccinated wherever they are.” They illustrate this with a hypothetical: “you might live in the middle of the desert, but it can still find you.” The claim is that the virus “is looking for you” among those who are unvaccinated, specifically mentioning people who are either unvaccinated or “have only had one jab and are not fully protected.” They further state that “the virus does seem to be finding older people who have not received that third dose.” The overarching claim is that “we’ll ultimately find just about everybody,” underscoring that the danger persists across different demographics and vaccination statuses. They illustrate this with a concluding anecdote: “these three people, two of them weren’t vaccinated. One had just had the first dose. The virus was found.”

Speaker 0 asked about the visibility of the medium to long-term effects of the vaccine in three to five years. Speaker 1 responded that they cannot predict how things will be in three to five years, but mentioned that 92-93% of the population will be vaccinated. Speaker 0 expressed confusion, and Speaker 1 clarified that 92-93% is the current vaccination rate. Speaker 0 raised concerns about potential side effects, but Speaker 1 reassured them that if there are any, the majority of the population would be affected. Speaker 0 remained unconvinced and expressed hesitation about getting vaccinated.

Every 12 hours, the virus produces a new generation, but statements claiming we can stay ahead of the virus are an insult to science. The immune status of vaccinated individuals is fundamentally different from that of the unvaccinated, as the unvaccinated develop stronger immune systems due to the circulating virus. However, the vaccine cannot prevent the spread of the highly infectious virus, leading to antibody-dependent enhancement of severe disease. Unvaccinated individuals may become a separate subspecies in terms of their health and ability to fight disease. The priority should be preventing children from getting vaccinated, as they have innate immunity that can develop into natural immunity.

The speakers discuss the concept of achieving herd immunity to stop the spread of the epidemic. Speaker 2 disagrees with this approach, stating that it would result in a significant number of deaths. They emphasize the need to prevent people from catching the virus and highlight the exponential increase in cases. Speaker 1 acknowledges the debate on herd immunity but doesn't believe anyone is advocating for intentionally causing deaths. Speaker 0 explains that there are two strategies: stamping out every case or achieving herd immunity. They mention the difficulty of containment and argue that achieving herd immunity is the only way to end the epidemic once the virus is widespread.